MyAverix Finance
US · Healthcare
Neurobiological Technologies Inc (NTII)
Biotechnology
Neurobiological Technologies Inc (NTII) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NTII
Neurobiological Technologies Inc (NTII) — FAQ
What is NTII's P/E ratio?
The price-to-earnings (P/E) ratio for Neurobiological Technologies Inc (NTII) is 18.00 (data as of 2026-03-24).
Does Neurobiological Technologies Inc pay a dividend?
Dividend yield is not available in the current snapshot for Neurobiological Technologies Inc (NTII). Check the MyAverix Finance app for the latest dividend data.
What sector is Neurobiological Technologies Inc in?
Neurobiological Technologies Inc (NTII) is classified in the Healthcare sector (Biotechnology industry).
What exchange is NTII listed on?
NTII is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.